RUSSO, Diego
 Distribuzione geografica
Continente #
NA - Nord America 4.405
AS - Asia 2.112
EU - Europa 1.467
SA - Sud America 150
AF - Africa 31
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 8.180
Nazione #
US - Stati Uniti d'America 4.220
SG - Singapore 1.386
IT - Italia 644
CN - Cina 456
SE - Svezia 286
GB - Regno Unito 180
DE - Germania 166
CA - Canada 157
BR - Brasile 130
IN - India 79
FI - Finlandia 56
TR - Turchia 51
BD - Bangladesh 23
ES - Italia 21
MX - Messico 21
VN - Vietnam 19
IR - Iran 18
UA - Ucraina 18
NL - Olanda 16
HK - Hong Kong 15
RO - Romania 14
EE - Estonia 13
JP - Giappone 12
AE - Emirati Arabi Uniti 10
FR - Francia 10
IQ - Iraq 10
PL - Polonia 9
EG - Egitto 8
SA - Arabia Saudita 7
ZA - Sudafrica 7
GR - Grecia 6
IE - Irlanda 6
AU - Australia 5
CL - Cile 5
PK - Pakistan 5
RU - Federazione Russa 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
BE - Belgio 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
JM - Giamaica 4
KR - Corea 4
MA - Marocco 4
TN - Tunisia 4
DZ - Algeria 3
EU - Europa 3
ID - Indonesia 3
IL - Israele 3
VE - Venezuela 3
AR - Argentina 2
CO - Colombia 2
ET - Etiopia 2
HR - Croazia 2
JO - Giordania 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
TW - Taiwan 2
UZ - Uzbekistan 2
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
KE - Kenya 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 8.180
Città #
Chandler 778
Singapore 473
Santa Clara 398
Princeton 360
Lawrence 359
Milan 350
Wilmington 197
Ashburn 151
Chicago 142
London 141
Munich 120
Ottawa 119
Des Moines 118
Boardman 66
Shanghai 57
Turku 45
Catanzaro 42
Council Bluffs 42
Los Angeles 40
Norwalk 37
Guangzhou 28
Shenzhen 25
Brooklyn 23
Beijing 22
Redwood City 22
Pune 21
Rome 18
São Paulo 18
Hanover 17
Istanbul 17
New York 17
Chennai 15
Hong Kong 15
Jiaxing 15
San Francisco 14
Washington 14
Montreal 13
Redmond 12
Seattle 12
Ankara 11
Delhi 11
Boston 10
Horia 10
Mexico City 10
Phoenix 10
Ann Arbor 9
Atlanta 9
Helsinki 9
Quanzhou 9
Xi'an 9
Abu Dhabi 8
Buffalo 8
Nottingham 8
Rui'an 8
The Dalles 8
Tokyo 8
Voghera 8
Warsaw 8
Wuhan 8
Wuxi 8
Catania 7
Columbus 7
Hanoi 7
Settingiano 7
Toronto 7
Assago 6
Baghdad 6
Collecorvino 6
Dongyang 6
Dublin 6
Ho Chi Minh City 6
Johannesburg 6
Naples 6
Paris 6
Rio de Janeiro 6
Salerno 6
Secaucus 6
Stockholm 6
Houston 5
Madrid 5
Nocera Inferiore 5
Shaoxing 5
Taranto 5
Xuzhou 5
Charlotte 4
Clifton 4
Dallas 4
Florence 4
Hamilton 4
Jeddah 4
Jinhua 4
Kingston 4
Lecce 4
Milwaukee 4
Mountain View 4
Napoli 4
Olomouc 4
Patna 4
Poplar 4
Porto Alegre 4
Totale 4.767
Nome #
Biological Activity of Oleuropein and Its Derivatives 159
Precision oncology for RET-related tumors 61
Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells 61
Hashimoto's thyroiditis and vestibular dysfunction 59
Anti-hTERT siRNA-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 59
Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases 59
A case of metastatic medullary thyroid carcinoma: early identification before surgery of a ret proto-oncogene somatic mutation in fine needle aspirate specimen 55
Impact of legumes and plant proteins consumption on cognitive performances in the elderly 55
Antiproliferative effects afforded by pyrazolopyrimidine derivates on human neuroblastoma cells 54
A case of anaplastic Diffuse Large B-Cell Thyroid Lymphoma: unique immunophenotype and unusual clinical presentation 53
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer 53
Association between low C-peptide and fragility fractures in postmenopausal women without diabetes 52
A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC 50
A Phe 486 TSH receptor mutation in a autonomously functioning follicular carcinoma that was causing hyperthyroidism 50
A novel mutation in the Thyrotropin receptor gene causing loss of TSH binding but constitutive activation in a family with resistance to TSH 49
A thyroid follicular cancer presenting as a hot nodule and hyperfunctioning because of an activating mutation of the TSH receptor 49
Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells 49
Antiproliferative and antioxidant effects of oleuropein and its semisynthetic peracetylated derivatives on breast cancer cells 49
Absence od Sodium/Iodide symporter gene mutations in differentiated human thyroid carcinomas 48
Expression and cellular localization of Ref-1 in human thyroid carcinoma cell lines 47
Antioxidant and antiproliferative effects of olive-leaf extract oleuropein and its peracetylated derivate on human thyroid cancer cells 46
A novel mutation in the thyrotropin receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistence to TSH 45
Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy 44
Anti-hTERT siRNA nanoparticles block the growth of anaplastic thyroid cancer cells in vitro and in vivo. 44
Antiproliferative activity of PDE5 inhibitors vehicled by nanovescicles in thyroid cancer cells. 44
Antiproliferative activity of PDE5 inhibitors vehicled by nanovesicles in thyroid cancer cells 43
Antiproliferative Effects of Two Pyrazolo-Pyrimidine Derivates on Human Anaplastic Thyroid Cancer Cells 43
Antiproliferative activity of PDE5 inhibitors vehicle by nanovesicles in thyroid cancer cells. 42
A hyperfunctioning Hurtle cell thyroid carcinoma with a mutation in the thyrotropin receptor 42
Adenyl cyclase activity and Gs and Gi alpha ADP-ribosylation in thyroid hyperfunctioning adenomas presenting TSH receptor or Gsp mutations 41
Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice 41
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells 40
Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. 40
A Val677 activating mutation of the thyrotropin receptor in a Hurtle cell thyroid carcinoma associated with thyrotossicosis 40
Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells 40
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with pheochromocytoma and medullary thyroid carcinoma: Functional characterization 40
A Val 677 activating mutation of the Thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis 40
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches. 39
Activating mutations of the TSH Receptor in differentiated thyroid carcinomas 39
Absence of Sodium-Iodide Symporter gene mutations in differentiated human thyroid carcinomas 39
Antiproliferative effects of olive-leaf extract oleuropein and derivatives in human breast cancer cells 39
Oleacein inhibits STAT3, activates the apoptotic machinery, and exerts anti-metastatic effects in the SH-SY5Y human neuroblastoma cells 39
APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfunctioning nodules 39
Ape1/Ref-1 is increased in nuclear fractions of human thyroid hot nodules 38
Alterazioni del trasportatore dello iodio in patologia tiroidea 38
Absence of iodide symporter gene mutations in human thyroid tumors 38
TSH-CONJUGATED NANOCARRIER FOR THE TREATMENT OF THYROID CANCER 38
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 37
MicroRNAs as Biomarkers in Thyroid Carcinoma 37
Valutazione Antitumorale in Vitro di Liposomi Contenenti Gemcitabina ed un Nuovo Inibitore Tirosin-Chinasico di Sintesi 37
Carcinoma midollare della tiroide: identificazione di una nuova mutazione 37
A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH 37
A new structural model for the Thyrotropin receptor as determined by covalent crosslinking of Thyrotropin to the recombinant receptor in intact cells: evidence for a single polypeptide chain. 36
Expression and localization of the sodium/iodide symporter (NIS) in testicular cells 35
A Val677 activating mutation of the thyrotropin receptor in a Hürtle cell thyroid carcinoma associated with thyrotoxicosis 35
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAFV600E mutation 35
Identification of thyroid-associated serum microrna profiles and their potential use in thyroid cancer follow-up 35
Multidrug Carriers Encapsulating Gemcitabine and Paclitaxel for the Treatment of Multi-Drug Resistant Tumors 35
Analysis of YAP1 expression in papillary thyroid cancer, lymph node metastases and medullary thyroid cancer. 35
Analisi della proteina APE/Ref-1 nei noduli tiroidei iperfunzionanti: aumento dell’espressione nelle frazioni nucleari 35
Functional interaction among thyroid specific transcription factors: PAX8 regulates the activity of Hex promoter 34
Regulation of sodium iodide symporter gene expression and protein levels in JAR human placental cell line 34
Aqueous–core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response 34
A novel germline VHL gene mutation in two different patients with pheochromocytoma. 34
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma. 34
Safety Evaluation of Subchronic Oral Administration of Oleuropein and its Semisynthetic Peracetylated Derivative 34
Control of PTEN gene expression in normal and neoplastic thyroid cells 33
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity 33
Expression of YAP1 in aggressive thyroid cancer 33
Phytochemicals in thyroid cancer: analysis of the preclinical studies 33
Expression patterns of the PDS and Sodium/Iodide (NIS) gene in human thyroid carcinoma cell lines and human thyroid tumors 32
hNIS protein in thyroid: the iodine supply influences its expression and localization 32
Tecnologia del DNA ricombinante nello studio delle malattie tiroidee autoimmuni. Identificazione della tireoperossidasi (TPO) 32
Secretome Analysis of Hypoxia-Induced 3T3-L1 Adipocytes Uncovers Novel Proteins Potentially Involved in Obesity 32
Epigenetic-related gene expression profile in Medullary Thyroid Cancer revealed the overexpression of the Histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 32
Complex regulation of thyroid-specific transcription factors expression: TTF-1 and PAX-8 control HEX promoter activity 32
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells 32
Dihydrotanshinone exerts antitumor effects and improves the effects of cisplatin in anaplastic thyroid cancer cells 32
Iodide symporter gene expression in human thyroid tumors 31
Effect of thyrotropin and cAMP on FRTL-5 cell growth in a serum free medium. 31
TSH-nanoliposomi: un nuovo strumento per il direzionamento dei farmaci alla tiroide 31
Molecular mechanisms involved in the increase of glucose transport in transformed FRTL-5 rat thyroid cells. 30
Modulation of thyroid specific gene expression in normal and nodular human thyroid tissues from adults: an in vivo effect of thyrotropin 30
Binding domains of stimulatory and inhibitory TSH receptors autoantibodies determined with chimeric TSH-LH/CG receptors. 30
Genetica molecolare delle tireopatie 30
Vestibular disorders in euthyroid patients with Hashimoto’s thyroiditis: role of thyroid autoimmunity. 30
Novel somatic MEN1 gene alterations in nonfamilial primary hyperparathyroidism and correlation with clinical characteristics 30
The cyclic AMP response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas 29
In vivo and in vitro characterizaton of a novel germline RET mutation associated with low-penetrant non-aggressive familial medullary thyroid carcinoma 29
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivate 29
Prevalence of TSH receptor mutations in thyroid autonomously hyperfunctioning adenomas 29
Iodide symporter gene expression in normal and transformed rat thyroid cells 29
Lack of relationship between cAMP desensitization and TSH receptor down-regulation in the rat thyroid cell line FRTL5 29
Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer 28
Sodium-iodide symporter in human thyroid tumors 28
Evaluation of biological effects of TERT inhibition in human thyroid cancer cells 28
Carcinomi differenziati della tiroide: ruolo oncogenico del recettore del TSH 28
Functional analysis of the cytoplasmic domains of the human TSH receptor by site-directed mutagenesis. 28
A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency. 28
An activating mutation in the thyrotropin receptor causing thyrotoxicosis in a Hurtle cell thyroid carcinoma 28
Totale 3.973
Categoria #
all - tutte 134.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.799


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 0 26 7 52 28 15 12 14 36 7 11 33
2021/2022873 4 3 7 185 117 11 37 210 80 59 147 13
2022/20232.398 738 98 73 186 246 204 5 174 351 135 146 42
2023/2024834 164 142 57 43 49 229 13 36 16 17 12 56
2024/20253.321 551 316 155 180 123 415 24 87 450 286 227 507
2025/2026393 243 150 0 0 0 0 0 0 0 0 0 0
Totale 8.357